Distinct roles for bFGF and NT-3 in the regulation of cortical neurogenesis  by Ghosh, Anirvan & Greenberg, Michael E.
Neuron, Vol. 15, 89-103, July, 1995, Copyright 0 1995 by Cell Press 
Distinct Roles for bFGF and NT-3 
in the Regulation of Cortical Neurogenesis 
Anitvan Ghosh’ and Michael E. Greenberg’ 
Department of Microbiology and Molecular Genetics 
Harvard Medical School 
Boston, Massachusetts 02115 
Summary 
To identify molecules that regulate the transition of 
dividing neuroblasts to terminally differentiated neu- 
rons in the CNS, conditions have been developed that 
allow the neuronal differentiation of cortical precursor 
cells to be examined in vitro. In these cultures, the 
proliferation of undifferentiated precursor cells is con- 
trolled by basic fibroblast growth factor (bFGF). The 
proliferative effects of bFGF do not preclude the action 
of signals that promote differentiation, since addition 
of neurotrophin-3 (NT-3) antagonizes the proliferative 
effectsof bFGFandenhancesneuronaldifferentiation. 
In addition, blocking NT-3 function with neutralizing 
antibodies leads to a marked decrease in the number 
of differentiated neurons, without affecting the prolif- 
eration of cortical precursors or the survival of postmi- 
totic cortical neurons. These observations suggest 
that bFGF and NT-3, by their distinct effects on cell 
proliferation and differentiation, are key regulators of 
neurogenesis in the CNS. 
Introduction 
A central focus of developmental neurobiology is to under- 
stand the role of extracellular signals in regulating differen- 
tiation in the nervous system, and over the past several 
years, this problem has been addressed at several levels. 
There is considerable evidence that diffusible signals play 
an important role, even in the earliest stages of nervous 
system development (reviewed in Jessell and Melton, 
1992). For example, the differentiation of neuroectoderm 
from the surrounding ectoderm can be influenced by 
mesoderm-derived signals. There has been recent prog- 
ress in defining the identity of neural inducers, and two 
molecules, follistatin and noggin, have emerged as likely 
mesodermal signals that regulate neural differentiation 
(Lamb et al., 1993; Hemmati-Brivanlou and Melton, 1994; 
Hemmati-Brivanlou et al., 1994). In a similar vein, but at 
a later stage of neural development, there is compelling 
evidence that notocord-derived factors regulate dorsoven- 
tral patterning in the spinal cord and may specifically be 
involved in motoneuron differentiation (Yamada et al., 
1993). 
At the time of neural induction and neural tube forma- 
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tion, all of the cells in the nervous system are still proliferat- 
ing, and further differentiation of neural cells into postmi- 
totic neurons and glia must await regionalization of the 
nervous system into its major subdivisions. Much of our 
knowledge of the sequence of events involved in neuro- 
genesis derives from studies of the developing cortex, and 
the major cellular events in this process appear to be con- 
served elsewhere in the CNS. At the time of regionaliza- 
tion, thecortexconsistsof a pseudostratified neuroepithel- 
ium, which contains proliferating precursor cells. As 
postmitotic neurons are generated, they migrate away 
from the neuroepithelium (ventricular zone) and form the 
cortical plate immediately below the pial surface. In the 
rat cortex, neurogenesis continues from about embryonic 
day13(E13;EOisdayofmating)toEl9(BayerandAltman, 
1990). This period is followed by the appearance of oligo- 
dendrocytes and astrocytes, which are generated during 
early postnatal development. 
Although the cellular events accompanying neurogen- 
esis in the cortex have been described extensively, the 
underlying cellular and molecular regulatory events are 
not well understood. The prevailing views of control of 
neurogenesis are, in fact, based largely on studies of neu- 
ral crest-derived cells (reviewed in Anderson, 1989; Pat- 
terson, 1990). Many of the early experiments dealing with 
the regulation of differentiation by extracellular signals 
were performed on the PC12 cell line, which adopts a 
sympathetic neuron-like phenotype upon exposure to 
nerve growth factor (NGF) and basic fibroblast growth fac- 
tor (bFGF; Greene and Tischler, 1976). Subsequently, the 
issue of regulation of differentiation has been examined 
in primaryculturesof precursorcells. Studieson thedevel- 
opment of sympathetic neurons in vitro indicate that these 
neurons arise from a bipotential sympathoadrenal precur- 
sor cell whose differentiated fate can be regulated by ex- 
tracellular signals. Whereas in the presence of glucocorli- 
coids these cells assume a chromaffin cell fate, bFGF and 
NGF induce some of these cells to differentiate into sympa- 
thetic neurons (Anderson and Axel, 1986). It appears that 
bFGF initiates neuronal differentiation of sympathoadrenal 
precursors, and NGF promotes their long-term survival 
(Stemple et al., 1988). Experiments on an immortalized 
sympathoadrenal progenitor cell line indicate that ciliary 
neurotrophic factor (CNTF), FGF, and NGF can coopera- 
tively promote the differentiation of these cells (Ip et al., 
1994). Recently, it has also been demonstrated that brain- 
derived neurotrophic factor (BDNF) promotes the differen- 
tiation of neural crest cells along a sensory neuron lineage 
(Sieber-Blum, 1991), and that BDNF and neurotrophin-3 
(NT-3) promote the maturation of embryonic chick sensory 
neurons in vitro (Wright et al., 1992), suggesting that these 
factors may be important regulators of neurogenesis in 
the PNS. 
Analogy with neurogenesis in peripheral nervous sys- 
tem suggests that growth factors are likely to be involved 
in regulating central neurogenesis as well (McKay, 1989). 
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Indeed, it has been demonstrated that bFGF is a potent 
mitogen for certain CNS populations (Gensburger et al., 
1987; Cattaneo and McKay, 1990; Ray et al., 1993; Ray 
and Gage, 1994; Kilpatrick and Bartlet, 1993) and it ap- 
pears that bFGF and NGF cooperatively promote the pro- 
liferation and differentiation of embryonic striatal neurons 
(Cattaneo and McKay, 1990). It has also been demon- 
strated that epidermal growth factor, FGF, and trans- 
forming growth factor a can influence the proliferation of 
retinal neuroepithelial cells (Anchan et al., 1991; Lillien 
and Cepko, 1992). These effects of bFGF are in contrast 
to the differentiation-promoting effects of bFGF on sympa- 
thoadrenal precursor cells and PC12 cells (both derived 
from the neural crest) and underscore the point that the 
role of specific factors in regulating CNS neurogenesis 
cannot be simply inferred from observations in the PNS. 
In the last several years, a number of new growth factors 
have been identified, and their expression has been local- 
ized to the developing CNS. Most notable among them 
are the NGF-related molecules BDNF, NT-3, and NT-4/5 
(referred to as NT-4 in this study), which are collectively 
called the neurotrophins (Leibrock et al., 1989; Hohn et 
al., 1990; Maisonpierre et al., 1990a; Berkemeier et al., 
1991; Hallbook et al., 1991). The expression of the neuro- 
trophins as well as their receptors suggests that they may 
be involved in regulating aspects of early CNS develop- 
ment. In particular, NT-3 and BDNF are expressed in the 
embryonic cortex (Maisonpierre et al., 1990b), and their 
receptors are present in the developing ventricular zone 
(Tessarollo et al., 1993; Allendoerfer et al., 1994; Escan- 
don et al., 1994; Lamballe et al., 1994). These and related 
observations (reviewed in Chao, 1992) support the possi- 
bility that neurotrophins may regulate proliferation and dif- 
ferentiation in the CNS. 
The direct assessment of the role of neurotrophins and 
other growth factors in regulating CNS neurogenesis un- 
der controlled conditions requires the development of ap- 
propriate in vitro systems in which the proliferation and 
differentiation of CNS precursor cells can be examined 
(McKay, 1989; Cataneo and McKay, 1990). Toward this 
goal, and specifically to address the issue of cortical neuro- 
genesis, we have developed culture conditions in which 
cells from the cerebral cortex are cultured at the onset of 
neurogenesis (E13-14) and in which neurons and glia are 
generated in appropriate developmental sequence. Our  
focus in this study has been to evaluate the role of extracel- 
lular signals in regulating the early development of cortical 
neurons, and we report on our findings that bFGFand NT-3 
strongly influence cortical neurogenesis by regulating the 
proliferation and differentiation of cortical precursor cells. 
Results 
Characterization of an In Vitro System to Study 
Proliferation and Differentiation of Embryonic 
Cortical Neurons 
In the rat, cortical neurons are generated in the ventricular 
zone between El3 and E19. The newly postmitotic neu- 
rons migrate away from the ventricular zone, and once 
they reach the cortical plate, they undergo morphologic 
differentiation and extend axons and dendrites. The transi- 
tion of neural precursor cells to differentiated neurons is 
also accompanied by antigenic changes. Whereas the 
precursor cells are immunoreactive for the intermediate 
filament nestin (Lendahl et al., 1990) the postmitotic neu- 
rons do not express nestin and instead express markers 
specific for differentiated neurons such as microtubule- 
associated protein 2 (MAP2; Matus et al., 1981) and TuJl 
(Geisert and Frankfurter, 1989). To examine the interac- 
tions that mediate cortical neurogenesis, we developed 
an in vitro system that would allow us to examine the prolif- 
eration and differentiation of embryonic cortical neurons 
under defined conditions. The development of cells in cul- 
ture was characterized by various criteria, including the 
expression of the development stage-specific antigens 
nestin, TuJl, and MAP2. 
Cultures were prepared from E13-14 animals (El4 cul- 
tures), a time when the first postmitotic neurons of the 
cortex are beginning to differentiate (see Experimental 
Procedures for details). The cerebral hemisphere was dis- 
sected and gently triturated with a fire-polished glass pi- 
pette, so that most of the cortex was reduced to clusters 
of 5-20 cells. The cells were then plated out in an L15 
serum-free medium (L15-SFM) at a density of 100 clusters 
per 18 mm well. To characterize the developmental stages 
of the cells at time of plating, cells were fixed 4-6 hr after 
plating and immunostained with antibodies against vari- 
ous neuronal and glial markers. As expected from the de- 
velopmental time at which the cells are isolated, <5% of 
the cells expressed markers for differentiated neurons 
(TuJl, MAP2) or differentiated glial cells (glial fibrillary 
acidic protein, galactorcerebroside; data not shown). How- 
ever, over 95% of the cells were nestin immunoreactive 
(Figure lA), indicating that at the time of plating, most of 
these clusters consisted of ventricular zone cells that had 
not yet differentiated. 
Serial examinations of these cultures over several days 
revealed a striking difference in behavior between precur- 
sors that had been dissociated into single cells and those 
that had remained in a cluster during plating. The singly 
dissociated cells (>95%) either immediately stopped divid- 
ing or divided only once in culture before becoming postmi- 
totic (Figure 2A). Notably, these singly dissociated cells 
survived and extended processes in the absence of exoge- 
nously added growth factors and expressed neuronal pro- 
teins such as MAP2, indicating that they had undergone 
neuronal differentiation (Figure 28). In contrast, cell num- 
ber in the clusters increased over the first few days in 
culture, indicating that the precursors in the clusters con- 
tinued to proliferate in vitro. The possibility that cells were 
undergoing proliferation and neuronal differentiation in 
vitrowasexamined moredefinit ivelybyimmunocytochem- 
ical methods. Bromodeoxyuridine (BrdU) labeling of these 
cultures on the day of plating confirmed that about 90% 
of the cells initially proliferated as determined by nuclear 
BrdU incorporation (Figure 1B). However,  over the first 
3-4 days in culture, there was a gradual decrease in the 
fraction of cells that incorporated BrdU and a correspond- 
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Figure 1. Characterization of El4 Cortex Cultures Growing in the Absence of Exogenous Growth Factors 
(A) lmmunostaining of a cluster of cells at El4 with a rabbit anti-nestin antibody after 4 hr in culture. 
(6) lmmunostaining of a cluster of cells at El4 and 1 DIV with an anti-BrdU antibody after berng labeled with BrdU on the day of culture. 
(C) lmmunostaining of a cluster of cells at El4 and 5 DIV with an anti-MAP2 antibody. 
(D-F) Anti-TuJl (visualized in [D] with a fluorescein-conjugated secondary antibody) and anti-MAP2 (vrsualized in [E] with a Texas Red-conjugated 
secondary antibody) label identical populations of cells with neuronal morphologies (double exposure shown in [F]) at El4 and 5 DIV. 
ing increase in ceils with clear neuronal morphology. By 
5 days in vitro (5 DIV), BrdU incorporation was sharply 
reduced (to <V/O), and the clusters were dominated by 
MAPP-positive neurons (>90%; Figure 1 C). The neuronal 
differentiation of the cells in culture was also confirmed 
by immunostaining cells for a second neuron-specific 
marker, TuJl, which in our cultures labeled a population 
of cells that were also MAP2 positive (Figures 1 D-l F). As 
A 
. 
Figure 2. Singly Dissociated El4 Cells Adopt Neuronal Phenotypes 
In Vitro 
(A) Cells isolated from El4 cortex were dissociated and cultured for 
24 hr in the presence of BrdU. Subsequent immunostaining with anti- 
BrdU indicates that in contrast to cells growing in clusters that incorpo- 
rate BrdU (see Figure 1 B), most singly dissociated cells do not incorpo- 
rate BrdU. (8) lmmunostaining of singly dissociated El4 cells after 5 
DIV with anti-MAP2 indicates that most of these cells adopt neuronal 
morphologies and express MAPP, a neuron-specific protein. 
shown in Figures lC-1 F, many of the MAP2- and TuJl- 
positive cells had extensive dendritic trees typical of mor- 
phologically differentiated neurons. Therefore, over the 
first few days in culture, there was a marked shift in the 
distribution of proliferating and differentiated cells in these 
cultures; whereas at the time of plating, over 90% of the 
cells were nestin positive and incorporate BrdU, by 5 DIV, 
the proliferating cells were almost entirely replaced by 
morphologically differentiated MAP2- and TuJl-positive 
neurons. These observations indicated that the signals 
that regulate proliferation and differentiation of embryonic 
cortical neurons continue to function in these cultures and 
prompted us to consider the possibility that growth factors 
are important regulators of neurogenesis under these cul- 
ture conditions. 
Multiple Growth Factors Activate Intracellular 
Signaling in Developing Cortical Neurons 
Growth factor stimulation of receptor tyrosine kinases 
leads to the activation of several intracellular signaling 
molecules. Prominent among them is MAP kinase, which 
is phosphorylated on tyrosine and threonine in response 
to a variety of extracellular signals (Boulton et al., 1991) 
and therefore can serve as a useful indicator of functional 
growth factor signaling pathways. To determine whether 
developing cortical neurons had signal-transducing growth 
factor receptors, we examined the ability of several growth 
factors (known to be expressed in the CNS) to induce MAP 
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kinase phosphorylation in embryonic and neonatal cortical 
cultures. Lysates from cells stimulated with bFGF, epider- 
mal growth factor, platelet-derived growth factor, CNTF, 
leukemia inhibitoryfactor(LIF), NGF, BDNF, NT-3, or NT-4 
were run on a polyacrylamide gel, transferred to nitrocellu- 
lose, and probed with phosphotyrosine antibodies to de- 
tect tyrosine phosphorylation of MAP kinase. Phosphory- 
lated MAP kinase is present as a distinct band of about 42 
kDa on these phosphotyrosine blots. As shown in Figure 3, 
in unstimulated cells, there are low levels of phosphory- 
lated MAP kinase. Stimulation with most growth factors 
led to a weak or undetectable increase in phosphorylated 
MAP kinase in El7 cortical cultures. However,  exposure 
to bFGF, BDNF, NT-3, and NT-4 led to a striking increase 
in MAP kinase phosphorylation, indicating that receptors 
for these four factors can signal very effectively in embry- 
onic cortical neurons (Figure 3A). The remaining factors 
(epidermal growth factor, platelet-derived growth factor, 
CNTF, LIF, and NGF)  were ineffective in leading to signifi- 
cant increases in tyrosine phosphorylation of MAP kinase 
over a range of concentrations (l-100 nglml; data not 
shown), indicating that this was not simply due to stimula- 
tion at suboptimal doses. To determine whether there were 
developmental changes in growth factor responsiveness 
in cortical neurons, similar experiments were performed 
on cultures from neonatal animals. Although the pattern 
of tyrosine phosphorylation in neonatal cortical cultures 
was quite similar to that in embryonic cultures, there was 
one notable difference. Whereas BDNF, NT-3, and NT-4 
were still very effective in inducing phosphorylation of MAP 
kinase, bFGF treatment led only to weak MAP kinase 
phosphorylation in cultures from neonatal cortex (Figure 
38). These experiments indicate that bFGF, BDNF, NT-3, 
and NT-4 are effective at activating intracellular signaling 
in embryonic cortical neurons, and that a developmental 
change in responsiveness restricts the action of bFGF so 
that it activates MAP kinase phosphorylation much more 
El7 + 1 DIV 
PO + 1 DIV 
Figure 3. Growth Factor-Induced Tyrosine Phosphorylation in Corn- 
cal Neurons 
Cultures of El7 (A) and PO (6) cortex were stimulated at 1 DIV for 5 
min with the growth factors indicated (50 rig/ml). Western blots of 
proteins were probed with phosphotyrosine antibodies. The position 
of MAP kinase (~42) is indicated by the arrowhead. Whereas BDNF, 
KT-3, and NT-4 effectively lead to MAP kinase phosphorylation in both 
El7 and PO cultures, bFGF is much more effective in signaling in El7 
cultures than in PO cultures. 
effectively in embryonic cortical neurons than in neurons 
from neonatal cortex. 
Whereas MAP kinase phosphorylation is a reliable indi- 
cator of receptor activation for growth factors that signal 
through receptor tyrosine kinases, its role in propagating 
signals in response to the activation of other receptors is 
not as well established. Of the growth factors examined, 
all except CNTF and LIF act through receptor tyrosine 
kinases. CNTF and LIF act through the activation of glyco- 
protein 130-linked receptors (Davis et al., 1991; Ip et al., 
1992). Therefore, it was possible that although CNTF and 
LIF did not lead to MAP kinase phosphorylation at the 
timepoint examined (5 min), they did activate intracellular 
signaling in these neurons via other pathways. It has pre- 
viously been shown that activation of various signaling 
pathways, including activation of the CNTF receptor, leads 
to the induction of the immediate early gene c-fos (Ip et 
al., 1992). Indeed, we found that stimulation of cortical 
neurons with CNTF or LIF led to increased expression 
of c-fos, although the level of induction was attenuated 
compared with stimulation with BDNF, NT-3, NT-4, or 
bFGF(Figure 4A; data not shown). Together, the results on 
MAP kinase phosphorylation and c-fos induction indicate 
that bFGF, BDNF, NT-3, NT-4, CNTF, and LIFcan activate 
intracellular signaling pathways in embryonic cortical 
neurons. 
Although MAP kinase phosphorylation and c-fos induc- 
tion are useful indicators of signaling in response to growth 
factor stimulation, they do not reveal whether these factors 
target distinct subsets of cortical neurons or whether these 
neurons can individually respond to multiple factors. To 
address this issue, we took advantage of the fact that it 
has been demonstrated recently that many growth factors 
lead to the activation of the transcription factor CAMP re- 
sponse element-binding protein (CREB), a regulator of 
c-fos transcription (Ginty et al., 1994). CREB activation 
requires phosphorylation at Ser133, and this event can 
be detected immunocytochemically using an antibody that 
specifically recognizes the phosphorylated form of CREB 
(Ginty et al., 1993). Whereas in unstimulated cortical neu- 
rons, less than 5% of the cells showed phosphoCREB 
immunoreactivity, stimulation with bFGF, BDNF, NT-3, 
NT-4, or CNTF led to CREB phosphorylation in over 90% 
of the cells in each case, indicating that most cortical 
neurons can respond to multiple growth factors (Figures 
4B-4D; data not shown). There was no clear correlation 
between cell morphology and the extent of CREB phos- 
phorylation in these neurons. However,  an analysis of the 
kinetics of CREB phosphorylation revealed a difference 
between factors such as BDNF that act through receptor 
tyrosine kinases and CNTF, which acts through glycopro- 
tein 130-linked receptors. CREB phosphorylation in re- 
sponse to bFGF, BDNF, NT-3, or NT-4 peaked by 10 min 
and remained elevated for several hours; in contrast, there 
was no detectable effect of CNTF on CREB phosphoryla- 
tion until about 1 hr, indicating adelayed kineticsof activa- 
tion in response to CNTF (Table 1). Also, the intensity of 
phosphoCREB immunoreactivity was significantly greater 
in response to the neurotrophins than in response to 
CNTF. These differences in the kinetics and extent of MAP 
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Figure 4. Growth Factor-Induced c-fos Expression and CREB Phosphorylation in Cortical Neurons 
(A) induction of c-fos expression. Cultures of El7 cortex were stimulated for 60 min with the growth factor indicated (50 nglml) before being 
harvested for RNA isolation. RNA blots were hybridized with a 32P-labeled probe to the coding region of c-fos. Of the growth factors examined, 
BDNF, NT-3, NT-4, bFGF, and CNTF led to detectable increases in c-fos expression. 
(B-D) Induction of CREB phosphorylation. Cultures of El7 cortex were stimulated for IO min with the growth factors indicated, and following 
fixation, the cultures were immunostained with an antibody to the phosphorylated form of CREB. Stimulation with bFGF or NT-3 leads to increased 
PCREB immunoreactivity in over 90% of the cells. 
kinase phosphorylation may reflect differences in the intra- 
cellular signaling pathways activated by these different 
factors that may be relevant to their distinct biological ef- 
fects. 
bFGF Regulates the Proliferation of Embryonic 
Cortical Neurons 
To determine whether the proliferation of cortical cells was 
regulated by growth factors, cultures were treated with 
various factors (40 rig/ml) immediately after plating, and 
their development in vitro was examined over the next 
several days. To detect proliferating cells specifically, cul- 
tures were labeled with BrdU after 4 DIV, and after an 
additional 24 hr, cells were fixed and processed for BrdU 
immunocytochemistry. Phase contrast microscopy in 
these cultures indicated that whereas there was no signifi- 
cant change in cluster size compared with controls when 
cells were treated with most growth factors, there was a 
marked increase in cluster size in cultures treated with 
bFGF (Figures 5A and 58). This apparent increase in cell 
Table 1. Kinetics of CREB Phosphorylation (El 7 Ctx) 
Factor 10 min 1 hr 4 hr 
Uns - - 
NGF - - - 
BDNF ++ ++ tt 
NT-3 tt t+ ++ 
NT-4 t+ ++ ++ 
bFGF ++ ++ ++ 
CNTF - + + 
Epidermal growth factor - - 
Platelet-derived growth - - - 
factor 
Phosphorylation of CREB at Ser133 was detected by immunostaining 
with an antrbody that specifically recognizes the phosphorylated form 
of CREB. PhosphoCREB immunoreactivity is scored here in terms of 
relative staining intensity: minus, no detectable staining; single plus 
sign, weak staining; double plus signs, intense staining. 
proliferation in response to bFGF was confirmed by exam- 
ining the distribution of BrdU-labeled cells. As shown in 
Figures 5C and 5D, in the presence of bFGF there was 
a striking increase in total cell number as well as in the 
number of cells that had incorporated BrdU. A comparison 
of the effects of various growth factors clearly indicates 
that whereas bFGF is very effective at promoting the prolif- 
eration of cortical cells, the other growth factors examined 
do not have such mitogenic activity (Figure 5E). 
bFGF promotes the proliferation of cortical cells at con- 
centrations likely to be in the physiologic range. Dose- 
response studies on both the number of clusters con- 
taining BrdU-positive cells (Figure 5F) and the number of 
BrdU-positive cells per cluster (Figure 5G)  indicate that 
the bFGF response is half maximal between 1 nglml and 3 
nglml. Significantly, however, bFGF led to the proliferation 
only of cells in clusters and not those that were dissociated 
as single cells (data not shown). Therefore, the ability of 
bFGF to promote cell proliferation appears to require cell- 
cell contact among precursor cells. 
To determine whether cells proliferating in the presence 
of bFGF retain properties of neuronal precursor cells, we 
examined whether dividing cells continue to express the 
precursor cell marker nestin. Cultures growing in bFGF 
for 4 DIV were labeled with BrdU for 24 hr and were subse- 
quently double-labeled with anti-BrdU and anti-nestin anti- 
bodies. As shown in Figure 6A, every BrdU-positive cell 
is also nestin positive. These observations indicate that 
although several of the growth factors examined can sig- 
nal effectively in cortical neurons, only bFGF cells pro- 
motes the proliferation of nestin-positive cortical precursor 
cells. 
Cells Undergo Terminal Cell Division and Neuronal 
and Glial Differentiation in bFGF-Treated 
Cultures 
Serial examination of cultures growing in the presence of 
bFGF indicated that the proliferation of cells in clusters 




entiated neurons. As shown in Figure 5H, although about 
90% of the cells growing in the presence of bFGF incorpo- 
rated BrdU during the first day in culture, by 7 DIV, the 
fraction of BrdU-positive ceils was reduced to about 70%. 
Correspondingly, there was an increase in the fraction of 
morphologically differentiated neurons from about 10% 
to 30% during the first 7 days in culture (Figure 51). 
Since neuronal differentiation in vivo is accompanied 
by a loss of nestin immunoreactivity, we examined whether 
morphologically differentiated neurons in culture similarly 
Figure 5. bFGF Promotes the Proliferation of 
Embryonic Cortical Cells 
(A and 6) Morphology of El 4 cortical cells visu- 
alized by phase contrast microscopy at 5 DIV 
when grown in the absence (A) or presence (6) 
of 40 rig/ml bFGF. 
(C and D)The distribution of BrdU-labeled cells 
in El4 cortical cultures at 5 DIV (labeled for 
24 hr, beginning at 4 DIV) when grown in the 
absence(C) or presence(D) of 40 nglml bFGF. 
(E) Quantitative effects of exogenous growth 
factors on the number of BrdU-positive cells 
per field of view (FOV). All growth factors were 
added to a final concentration of 40 nglml. 
(F) Number of clusters per FOV that include 
BrdU-positive cells at El4 and 5 DIV as a func- 
tion of bFGF concentration (indicated in nglml). 
(G) Number of BrdU-positive cells per cluster 
at El 4 and 5 DIV as a function of bFGF concen- 
trations (indicated in rig/ml). 
(H) Percentage of cells that are BrdU positive 
in bFGF-treated cultures as a function of days 
in culture. 
(I) Percentage of cells that are morphologically 
differentiated, BrdU-negative neurons in bFGF- 
treated culturesasafunctionofdaysin culture. 
down-regulated nestin expression and expressed neu- 
ronal markers. As shown by double immunofluorescence 
in Figure 6B, after 5 DIV in the presence of bFGF, cells 
expressing the neuronal markerTuJ1 no longer expressed 
the precursor cell marker nestin. The appearance of differ- 
entiated neurons in bFGF-treated cultures was also con- 
firmed by double-labeling the cultures with BrdU and 
MAP2. As shown in Figure 6C, at 5 DIV the cells with 
neuronal morphology are MAP2 positive and are postmi- 
totic, based on the fact that they do not incorporate BrdU. 
Figure 6. Characterization of El4 Cultures Growing in the Presence of 40 nglml bFGF 
(A) Double immunofluorescence of cultures at El4 and 5 DIV labeled with anti-nestin (red) and anti-BrdU (green). Cells were labeled with BrdU 
during the last 24 hr in culture. 
(B) Double immunofluorescence of cultures at El4 and 5 DIV labeled with anti-nestin (red) and anti-TuJl (green). Note that anti-nestin and anti-TuJl 
label distinct cell populations. 
(C) Double immunofluorescence of cultures at El4 and 5 DIV labeled with anti-BrdU (green) and anti-MAP2 (red). Cells were labeled with BrdU 
during the last 24 hr in culture. Note that the dividing (BrdU positive) cells are a distinct population from the postmitotic neurons (MAP2 positrve). 
(D) Double immunofluorescence of cultures at El4 and 5 DIV labeled with anti-BrdU (green) and anti-MAP2 (red). Cells were continuously labeled 
with BrdU beginning at 1 DIV. This experiment indicates that cells that proliferate in culture (BrdU positive) are capable of differentiating into 
postmitobc neurons (MAP2 positive). 
(E) Double immunofluorescence of cultures at El4 and 5DIV labeled with anti-BrdU (green) and anti-Trk (red). Cells were labeled with BrdU dunng 
the last 24 hr in culture. Note that proliferating (BrdU-positive) cells express Trk receptors. 
(F) Cells labeled with anti-galactocerebroside and visualized by DAB immunocytochemistry at El4 and 12 DIV. 
In these photomicrographs, yellow labeling indicates regions of double labeling due to colocalization of Texas Red- and fluorescein-conjugated 
secondary antibodies 
These observations indicate neurons that differentiate in 
culture undergo biochemical and cellular transitions typi- 
cal of cortical neurons that differentiate in vivo. 
The increase in cells expressing neuronal markers in 
bFGF-treated cultures could either be due to up-regulation 
of neuronal markers by cells that were already postmitotic 
at the time of plating or due to neuronal differentiation of 
cells that had undergone at least one round of cell division 
in the presence of bFGF in vitro. To determine whether 
cells dividing in the presence of bFGF contributed to the 
population of postmitotic neurons in our cultures, cultures 
were labeled with BrdU 1 day after plating, and the fates 
of BrdU-labeled cells were examined after 5 DIV. Cells 
that had undergone division in culture were identified by 
visualizing BrdU-labeled cells, and postmitotic neurons 
were identified by visualizing MAP2-positive cells. Over  
85% of the cells in these cultures were BrdU-positive, indi- 
cating that most El4 cells in our cultures divided at least 
once in vitro (data not shown). More importantly, we found 
that over 60% of the cells that were immunoreactive for 
MAP2 were also BrdU positive, indicating that cells that 
proliferate in bFGF-treated cultures have the capacity to 
differentiate into neurons (Figure 6D). 
The generation of differentiated neurons and glia in vivo 
is temporally separated. In the rat, all of the neurons are 
generated during embryonic development, and differenti- 
ated oligodendrocytes and astrocytes appear predomi- 
nantly at postnatal ages. To determine whether bFGF was 
a mitogen only for neuronal precursor cells or whether 
glial precursors also proliferated in response to bFGF, we 
examined the expression of glia-specific antigens in long- 
term El4 cultures. During the first 7-10 days in culture, 
less than 2% of the cells had either astrocyte or oligoden- 
drocyte morphologies, and most cells were not immunore- 
active for glia-specific markers (galactocerebroside and 
glial fibrillary acidic protein). Instead, as described above, 
they were immunoreactive for nestin or MAP2 and TuJl. 
However,  between 10 and 12 days in culture, the proliferat- 
ing cells(which, owing to their exponential growth, account 
for over 90% of the cells by 10 DIV) underwent a striking 
morphological transformation and adopted a morphology 
typical of oligodendrocytes. As shown in Figure 6F, over 
90% of the nonneuronal cells were intensely immunoreac- 
tive for galactocerebroside, indicating that these cells had 
indeed undergone oligodendrocyte differentiation. 
Typically, we do not see the appearance of astrocytes 
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in these cultures grown in defined media. In serum con- 
taining media, however, astrocytes are generated in large 
numbers, which suggests that the absence of astrocytes 
in our cultures may reflect the absence of an astrocytic 
differentiation signal that is present in serum (data not 
shown). Together, these observations indicate that bFGF 
promotes the proliferation of cortical precursor cells that 
are capable of undergoing terminal differentiation into 
both neurons or oligodendrocytes in the absence of other 
added factors. Moreover, the sequential appearance of 
neurons and glia in these cultures is further evidence that 
under these conditions the cells retain properties that 
would be typical of their development in vivo. 
NT-3 Is a Key Regulator of Cortical Neurogenesis 
The observation that cells can undergo terminal cell divi- 
sion and neuronal differentiation in vitro suggests that fac- 
tors that regulate these events are likely to be produced 
by cortical cells and can act effectively in culture. Of the 
growth factors that we found to be effective in signaling in 
cortical neurons, only bFGF, NT-3, and BDNF have been 
reported to be expressed in the embryonic cortex. Since 
bFGF appears to act primarily as a mitogen for neural 
precursor cells, we considered the possibility that NT-3 or 
BDNF might regulate the transition of neural precursor 
cells to differentiated neurons. 
The possibility that BDNFor NT-3 may regulate neuronal 
differentiation would require that their receptors be ex- 
pressed in the cortical precursor cells. The neurotrophins 
signal through receptors belonging to the Trk family of 
receptor tyrosine kinases (reviewed in Glass and Yanco- 
poulos, 1993). Reports on the expression of neurotrophin 
receptors indicate that Trk receptors are indeed expressed 
in the ventricular zone during development (Allendoerfer 
et al., 1994; Escandon et al., 1994). However,  it has not 
been demonstrated conclusively that dividing cells ex- 
press neurotrophin receptors. To determine whether pro- 
liferating cortical precursor cells express neurotrophin re- 
ceptors in vitro, after 4 DIV we labeled embryonic cultures 
grown in bFGF with BrdU for 24 hr and then examined 
the distribution of neurotrophin receptor-expressing cells 
and proliferating precursor cells by immunostaining with 
anti-Trk and anti-BrdU antibodies. (The anti-Trk antibody 
used recognizes all known Trk family receptors: TrkA, 
TrkB, and TrkC [D. Kaplan, personal communication; A. 
Ghosh and M. E. Greenberg, unpublished data].) As 
shown in Figure 6E, virtually all of the cells in the culture 
are Trk positive, and all BrdU-positive cells also show Trk 
immunoreactivity, indicating that cells that incorporate 
BrdU express neurotrophin receptors. The colocalization 
of BrdU and Trk indicates that proliferating cells express 
Trk receptors in vitro before undergoing terminal neuronal 
differentiation. 
To address the possibility that endogenous neurotro- 
phins may be involved in regulating neuronal differentia- 
tion, we examined the consequences of blocking NT-3 or 
BDNF function in culture using neutralizing antibodies. 
We have previously reported on the generation of highly 
specific antibodies against BDNF and NT-3 (Ghosh et al., 
1994). Data regarding specificity of anti-BDNF is already 
published (Ghosh et al., 1994); experiments demonstra- 
ting the specificity of anti-NT-3 are described here. On  
Western blots of recombinant proteins, anti-NT-3 recog- 
nizes NT-3 but not the related neurotrophins BDNFor NGF 
(Ghosh et al., 1994; J. Carnahan, personal communica- 
tion), indicating that anti-NT-3 does not nonspecifically 
cross-react with other neurotrophins. To determine 
whether anti-NT-3 specifically blocks signaling by NT-3 in 
cortical neurons, we took advantage of the fact that the 
expression of the immediate early gene c-fos is strongly 
induced by the neurotrophins BDNF, NT-3, and NT-4. As 
shown in Figure 7, preadsorption with anti-NT-3 com- 
pletely inhibited induction of c-fosexpression by NT-3, but 
did not affect the ability of BDNF or NT-4 to induce c-fos 
expression in cortical neurons. These experiments indi- 
cate that anti-NT-3 recognizes and specifically inhibits sig- 
naling by NT-3 without interfering with the actions of even 
closely related molecules. Moreover, anti-NT-3 does not 
inhibit differentiation of PC12 cells in response to NGF, 
indicating that it does not nonspecifically affect neuronal 
differentiation (data not shown). 
As we previously reported, anti-BDNF severely affects 
the survival of cortical neurons in culture (Ghosh et al., 
1994). In preliminary experiments on El4 cultures, we 
found it difficult to distinguish between the survival effects 
of BDNF and the role that it may play in promoting neuronal 
differentiation, since in either case, blocking BDNF func- 
tion would lead to a decrease in total neuron numbers. 
To determine whether this would also be a confounding 
issue in evaluating the role of NT-3, we examined the ef- 
c-fos 
Figure 7. Specificity of Anti-NT-3 Antibodies 
Culturesfrom El7cortexwerestimulatedfor 1 hrwith indicatedgrowth 
factors (50 rig/ml) or growth factors preadsorbed with anti-NT-3 before 
being harvested for RNA isolation. RNA blots were hybridized with a 
32P-labeled probe to the coding region of the c-fos gene. Anti-NT-3 
effectively blocks NT-3-induced c-fos expression in these cells without 
interfering with c-fos induction by SDNF or NT-4. 




















Figure 8. Anti-NT-3 Does Not Affect the Sur- 
vival of Postmitotic Cortical Neurons in Culture 
Cortex cultures at E17-18 and 1 DIV (A and 
B) or PO and 8 DIV (C and D) were treated for 
48 hr with a control turkey serum (A and C) or 
anti-NT-3 (B and D). In neither case did anti- 
NT-3 lead to detectable cell loss. 
(A and B) Phase contrast microscopy of live 
cells. 
(C and D) MAP2 immunoreactivity in paraform- 
aldehyde-fixed cells. 
(E) Quantitative effects of anti-NT-3 treatment 
(48 hr) on neuronal survival in E17-18 cortex 
cultures. 
fects of blocking NT-3 function on the survival of postmi- 
totic neurons. Experiments were carried out on E17-18 
cultures after 1 DIV or on PO cultures after 8 DIV. In both 
cases, cells were treated for 48 hr with a control serum 
or anti-NT-3. As shown in Figures 8A-8E, in neither case 
was there a detectable effect of anti-NT-3 on the survival 
of neurons. Thus, in contrast to anti-BDNF (Ghosh et al., 
1994), anti-NT-3 appears not to influence the survival of 
postmitotic cortical neurons. 
Given the expression of neurotrophin receptors on corti- 
cal precursor cells and our observation that anti-NT-3 did 
not significantly affect neuronal survival, we next consid- 
ered the possibility that endogenous NT-3 might function 
as a regulator of neuronal differentiation. As shown in Fig- 
ure 9A, there is normally an increase in the number of 
differentiated neurons per cluster over the first 7 DIV. To 
examine the role of NT-3 in neuronal differentiation, El4 
cultures growing in the presence of bFGF were treated 
with a control serum or anti-NT-3. After 6 DIV, cells were 
labeled with BrdU for 24 hr, and following fixation, cultures 
were immunostained with anti-MAP2 and anti-BrdU anti- 
bodies As shown in Figure 9B, there was a striking de- 
crease in the number of MAP2-positive neurons in cultures 
growing in the presence of anti-NT-3. Examination of the 
cultures indicated that although neuron numbers were dra- 
matically reduced in the presence of anti-NT-3, the mor- 
phology of the neurons that were present did not show 
signs of atrophy (Figures lOA, lOB, lOD, and 10E). This 
is consistent with the earlier observation that survival of 
postmitotic neurons in vitro was not affected by anti-NT-3 
(see Figure 8) and supports the interpretation that anti- 
NT-3 was having an effect prior to terminal differentiation. 
If anti-NT-3 were to influence the proliferation of cortical 
precursors, it could indirectly lead to a reduction in the 
number of differentiated neurons. This, however, appears 
not to be the case, since BrdU labeling experiments indi- 
cated that cell proliferation was not affected by anti-NT-3 
(Figure 9C; Figures 1OC and 1OF). Together, these obser- 
vations strongly suggest that neuronal differentiation in 
these cultures is dependent upon NT-3 function. 
To determine whether levels of endogenous NT-3 were 
limiting for the induction of neuronal differentiation, we 
next examined the effects of adding NT-3 to cultures grow- 
ing in the presence of bFGF. When control and NT-3- 
treated cultures were examined at 7 DIV, there were no 
significant differences in the number of differentiated neu- 
rons between the two treatments (data not shown). How- 
ever, when cultures were examined at 4 DIV, there were 
significantly more differentiated neurons in the NT-3- 
treated cultures (Figure 9D) than in controls. The fact that 
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Figure 9. Quantitative Analysis of the Effects of Anti-NT-3 and Exogenously Added NT-3 on Neuronal Differentiation in El4 Cultures 
In each of these experiments, cells were grown in the presence of 40 nglml bFGF. 
(A) Number of MAP2positive neurons per cluster as a function of days in culture. 
(8) Number of MAP2-positive neurons per cluster at 7 DIV in cultures grown in the presence of a control turkey serum (01) or anti-NT-3 
(C) Number of BrdU-positive cells per cluster at 7 DIV in cultures growing in the presence of a control turkey serum (Ctl) or anti-NT-3. Cells were 
labeled with BrdU during the last 24 hr in culture. 
(D) Number of MAP2-positive neurons per cluster at 4 DIV in cultures grown in the absence or presence of added NT-3 (100 nglml). 
(E) Number of BrdU-positive cells per cluster at 4 DIV in cultures growing in the absence or presence of added NT-3 (100 rig/ml). Cells were 
labeled with BrdU during the last 24 hr in culture. 
added NT-3 has an effect on neuron number at 4 DIV, but 
not at 7 DIV, suggests that exogenous NT-3 may act to 
accelerate neuronal differentiation without influencing the 
eventual number of neurons generated. BrdU labeling ex- 
periments indicated that the increase in the number of 
differentiated neurons at 4 DIV was accompanied by an 
apparent decrease in cell proliferation (Figure 9E). There- 
fore, exogenous NT-3 appears to suppress proliferation 
and promote neuronal differentiation of cortical precursor 
cells. These experiments complement the NT-3 blocking 
experiments described above, and together they strongly 
suggest that NT-3 is a key regulator of differentiation of 
cortical neurons. 
Discussion 
To determine the role of extracellular signals in regulating 
neurogenesis in the developing nervous system, we have 
examined the effects of peptide growth factors on the pro- 
liferation and differentiation of embryonic cortical cells. We 
find that proliferation of cortical precursor cells is primarily 
controlled by bFGF, which leads to an expansion of the 
precursor cell population. Subsequently, the transition of 
precursor cells to morphologically and biochemically dif- 
ferentiated neurons is regulated by NT-3. These observa- 
tions indicate that neurogenesis in the CNS is controlled 
at multiple levels and is strongly influenced by the actions 
A 0 Cd. Figure IO. Effects of Anti-NT-3 on Neuro- 
genesis 
El4 cortical cells grown in the presence of 40 
nglml bFGF treated with control turkey serum 
(A-C)orwithanti-NT-3(D-F).AtEl4and7DIV, 
cultures treated with anti-NT-3 show a marked 
reduction in the number of MAPSposit ive neu- 
rons (D) compared with controls (A). Higher 
magnification views (B and E) indicate that anti- 
NT-3 treatment does not lead to detectable at- 
rophyof the differentiated neurons. BrdU label- 
ing during the last 24 hr in culture (C and F) 
indicates that anti-NT-3 treatment does not 
lead to a detectable decrease in cell prolifer- 
ation. 
a-NT3 
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of bFGF and NT-3, which exert their effects by regulating 
the proliferation and differentiation of neuronal precursor 
cells. 
Development of Cortical Cells in El4 
Cluster Cultures 
The analysis of factors that influence CNS neurogenesis 
was facilitated by developing culture conditions that al- 
lowed us to monitor the proliferation and differentiation 
or embryonic cortical neurons. These cultures differ from 
more commonly used cortical cultures in three important 
respects. First, they are prepared from animals at E14, 
which is at the onset of cortical neurogenesis and allows 
one to examine the earliest steps of neuronal differentia- 
tion. Second, theyaregrown in achemically defined media 
in which the effects of exogenous factors on development 
can be clearly evaluated. Third, the cultures consist of 
small clusters of precursor cells that allow for normal cell- 
cell interactions to regulate development as they would 
in vivo. This final point is particularly important because 
we feel that it allows the role of endogenously produced 
extracellular and intracellular signals that regulate cortical 
neurogenesis to be evaluated by in vitro perturbation 
studies. 
The development of cells in El4 cultures provides sev- 
eral insights about the role of cell-cell interactions in corti- 
cal neurogenesis. First, we find that in the absence of 
added growth factors, singly dissociated cells from El4 
cortex do not undergo cell division, whereas those in cius- 
ters proliferate for several days before leaving the cell cy-  
cle. This observation suggests that the proliferation of cor- 
tical precursor cells requires cell-cell interactions. In light 
of these observations, it is noteworthy that it has recently 
been reported that in serum-containing media, groups of 
cells proliferate more extensively than single cells (Temple 
and Davis, 1994). Second, the fact that most singly dissoci- 
ated cells at El4 underwent neuronal differentiation sug- 
gests that direct cell-cell interactions are not required for 
precursors to differentiate into postmitotic neurons. Third, 
in the absence of added growth factors, we find over 90% 
of the cells in clusters differentiate into neurons by 5 DIV. 
This is striking, since precursor cells in our cultures are 
capable of giving rise to both neurons and glia in the pres- 
ence of bFGF. One possibility is that at early develop- 
mental stages, most precursors are committed to a neu- 
ronal lineage. Alternatively, many of the precursors may 
be bipotential, and bFGF may act to inhibit (but not com- 
pletely suppress) neuronal differentiation of these cells. 
Regulation of Cell Proliferation by bFGF 
Our experiments indicate that the proliferation of cortical 
precursor cells is positively regulated by bFGF. The prolif- 
erative effect of bFGF on cortical precursor cells is similar 
to the effects of bFGF reported previously on other CNS 
populations (Cataneo and McKay, 1990; Kilpatrick and 
Bartlet, 1993; Ray and Gage, 1994; Ray et al., 1993; De- 
Hamer et al., 1994) and suggests that bFGF functions 
widely to promote the proliferation of CNS precursor cells. 
Our observations on the proliferative effects of bFGF, how- 
ever, differ from previous observations in some respects 
that deserve comment. In cultures of striatal precursor 
cells, Cataneo and McKay reported that whereas bFGF 
alone was not very effective in promoting cell proliferation, 
it synergistically acted along with NGF to promote cell 
division. In our cultures, bFGF functions quite effectively 
in the absence of NGF, and we see no enhancement of 
the proliferative response to bFGF in the presence of NGF 
(A. Ghosh and M. E. Greenberg, unpublished data). In 
fact, all of our evidence suggests that NGF does not signal 
(at least through receptor tyrosine kinase activation) in 
cortical cells. More recently, Ray and Gage reported that 
high concentrations of bFGF maintain hippocampal neu- 
rons in proliferative cells for several weeks without appar- 
ent phenotypic changes over time in culture. In contrast, 
in our experiments, the proliferating precursor cells under- 
went a fairly synchronous transition to oligodendrocytes 
after about 10 days in culture. It is possible that these 
hippocampal cultures do not contain oligodendrocyte pre- 
cursors, which may suggest a simple explanation for this 
observed difference. A definitive resolution of these differ- 
ences will be important for a more complete understanding 
of control of proliferation of specific CNS precursor popula- 
tions. 
The proliferative effect of bFGF on cortical precursor 
cells is consistent with the high level of expression of bFGF 
and FGF receptors in the proliferative (ventricular) zone 
of the developing cortex (Gonzalez et al., 1990; Powell et 
al., 1991; Wanaka et al., 1991). Since cells in the El4 
cultures continue to proliferate for the first few days in vitro 
even in the absence of exogenously added bFGF, it is 
possible that endogenously produced bFGF regulates the 
proliferation of embryonic cortical neurons in our cultures. 
In support of this possibility, preliminary experiments sug- 
gest that neutralizing antibodies against bFGF (which rec- 
ognize bFGF and not acidic FGF) suppress the prolifera- 
tion of El4 cortical neurons (A. Ghosh and M. E. 
Greenberg, unpublished data). 
The high levels of FGF receptor expression on cortical 
precursor cells suggests that bFGF most likely acts on the 
precursors directly to promote cell division and therefore 
acts as a mitogen for these cells. However, since the prolif- 
erative effects of bFGF are evident only in cells growing 
in clusters, it is possible that bFGF induces the precursor 
cell to release a mitogen that then acts on neighboring 
cells within a cluster. It is also possible that direct cell- 
cell interactions are required in addition to bFGF signaling 
to cause precursor cells to divide. This would be consistent 
with the observations of Temple and Davis (1994) that 
membrane-associated factors promote the proliferation of 
cortical precursor cells. Although at present we cannot 
distinguish among these possible modes of bFGF action, 
our experiments provide evidence that bFGF is an im- 
portant and effective regulator of proliferation of cortical 
precursor cells. 
Our observations also indicate that although bFGF pro- 
motes Cell proliferation, it does not preclude the action of 
signals that induce neuronal and glial differentiation. Since 
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the appearance of differentiated neurons in bFGF-treated 
cultures precedes the appearance of differentiated oligo- 
dendrocytes, an interesting possibility is that the precursor 
that gives rise to neurons early in development may, over 
subsequent divisions, gain competence to give rise to oli- 
godendrocytes. Such a change in competence may even 
be influenced by the neurons that are generated during 
the early divisions. The recent observations on the exis- 
tence of multipotent stem cells in the embryonic cortex 
at least in principle allow for such a mechanism in the 
generation of oligodendrocytes (Davis and Temple, 1994). 
Regulation of Neuronal Differentiation by NT-3 
An important finding of this study is that NT-3 can regulate 
the neuronal differentiation of cortical precursor cells, We 
show that addition of NT-3 enhances neuronal differentia- 
tion, and that blocking endogenous NT-3 function with 
neutralizing antibodies markedly inhibits neuronal differ- 
entiation of cortical precursor cells. Since our conclusions 
rely in part on the use of neutralizing antibodies, the issue 
of their specificity deserves comment. The antibodies 
against NT-3 show remarkable specificity considering the 
homology among the various neurotrophins. These anti- 
bodies recognize recombinant NT-3 but do not cross-react 
with recombinant NGF, BDNF, or NT-4 on Western blots, 
They are also effective in specifically blocking NT-3 signal- 
ing, since they block NT9-induced c-fos expression in cor- 
tical neurons without affecting the induction of c-fos in 
these cells by BDNF or NT-4. Anti-NT-3 antibodies also do 
not influence NGF differentiation of PC12 cells, indicating 
that they do not nonspecifically interfere with differentia- 
tion. These various specificity controls strongly suggest 
thatobserved effectsof anti-NT-3on cortical neurogenesis 
are indeed due to the disruption of NT-3-mediated events 
in these cells. 
The involvement of NT-3 in regulating neuronal differen- 
tiation is consistent with a number of recent observations 
that suggest that neurotrophins can influence neuronal 
development prior to terminal differentiation. For example, 
BDNF, NT-3, and their receptors are expressed in devel- 
oping sensory and sympathetic ganglia, suggesting that 
they may play a role in the early development of neural 
crest-derived cells (Schecterson and Bothwell, 1992). In- 
deed, it has been shown that NT-3 and BDNF promote 
the maturation of chick DRG cells in culture (Wright et al., 
1992), and that NT-3 promotes the survival of proliferating 
sympathetic neuroblasts (DiCicco-Bloom et al., 1993; Bir- 
ren et al., 1993). A recent report also indicates that NT-3 
treatment leads to an increase in the number of islet 
l-positive cells in quail neural tube cultures, suggesting 
that NT-3 may be involved in motoneuron differentiation 
(Averbuch-Heller et al., 1994; Pinto et al., 1993). Both 
NT-3 and its receptor, TrkC, are expressed in the devel- 
oping cortex (Maisonpierre et al., 1990b; Tessarollo et al., 
1993; Lamballe et al., 1994). Moreover, NT-3 expression in 
the brain appears to be at its highest during the embryonic 
period (Maisonpierre et al., 1990b). These observations, 
together with our finding that NT-3 regulates the neuronal 
differentiation of cortical precursorcells, suggestthat NT-3 
is likely to be a key regulator of neurogenesis in both the 
central and peripheral nervous systems. 
Although our experiments indicate that NT-3 can influ- 
ence neuronal differentiation, it is likely that other factors 
contribute to the process as well, since animals with tar- 
geted disruptions of NT-3 or TrkC do not have a clear 
deficit in neuronal differentiation (Ernfors et al., 1994; Klein 
et al., 1994). Although an analysis of cortical development 
in these animals has not yet been reported, the brain ap- 
pears to be grossly normal at birth. Although it is possible 
that other factors can compensate for the loss of NT-3 or 
TrkC, adetailed analysis of neurogenesis in these animals 
could be instructive, since they may reveal subtle but im- 
portant abnormalities. We should also note that in our ex- 
periments, even at high concentrations of NT-3 only about 
30% of the cells in bFGF-treated cultures differentiated 
into neurons. Therefore, NT-3 may be capable of inducing 
neuronal differentiation only in a subset of neuronal pre- 
cursors. It is not yet clear whether this is due to differences 
in TrkC expression within precursor cells or whether some 
other lineage restriction limits the effects of NT-3 on neu- 
ronal differentiation. 
Though the precise mechanism by which NT-3 regulates 
differentiation is not clear, our observations suggest that 
NT-3 acts, at least in part, by promoting the withdrawal 
of precursor cells from the cell cycle. It has been reported 
previously that ventricular zone cells express neurotrophin 
receptors (Tessarollo et al., 1993; Allendoerfer et al., 1994; 
Lamballe et al., 1994) and that cortical cells are most re- 
sponsive to neurotrophins during the period of differentia- 
tion (Knusel et al., 1994). We show here that dividing pre- 
cursor cells express Trk receptors and that NT-3 can inhibit 
the mitogenic effects of bFGF on these cells. These obser- 
vations indicate that NT-3 inhibits the proliferation of corti- 
cal precursor cells and suggest that withdrawal from the 
cell cycle may be a critical step in neuronal differentiation. 
Although the mechanism by which NT-3 suppresses pro- 
liferation is not known, one possibility is that a critical 
level of bFGF-induced activation of signaling molecules 
is required to keep precursor cells dividing and NT-3 
antagonizes the proliferative effects of bFGF by inhibiting 
bFGF-induced intracellular signaling. In this regard, it is 
noteworthy that we find a developmental decrease in 
bFGF-induced MAP kinase phosphorylation in cortical 
neurons that is temporally correlated with cessation of cell 
proliferation in the developing cortex. We should note, 
however, that it is not yet known whether the decrease in 
bFGF-responsiveness in cortical cells occurs prior to or 
subsequent to withdrawal from the cell cycle. 
In summary, based on the expression patterns of various 
growth factors and their receptors, as well as our findings 
described here and previously (Ghosh et al., 1994) the 
following hypothesis emerges regarding growth factor 
control of early cortical development (Figure 11). The pro- 
liferation of cortical precursor cells appears to be regulated 
by bFGF in the ventricular zone. Subsequently, NT-3 acts 
to promote cell cycle withdrawal and neuronal differentia- 
tion of at least some of the precursor cells, and BDNF and 







Figure 11. Diagrammatic View of the Developing Cortex Indicating 
the Events Likely to Be Influenced by Growth Factor Action 
The diagram is based on results of this and previous studies. VZ, 
ventricular zone; 12, intermediate zone; CP, cortical plate. 
bFGF act as trophic factors for the postmitotic neurons 
(Morrison et al., 1966; Ghosh et al., 1994; A. Ghosh and 
M. E. Greenberg, unpublished data). Although such a 
scheme is perhaps oversimplified and does not take into 
account the likely involvement of other regulatory factors, 
it conveys the central idea that growth factors regulate 
specific and distinct aspects of cortical development. A 
similar framework, in which NT-3 and BDNF regulate dis- 
tinct aspects of cerebellar development, has recently been 
proposed (Segal et al., 1992). The exploration of the mech- 
anisms by which specific growth factors regulate these 
effects should provide us with a clearer understanding of 
the molecular mechanisms that control CNS development. 
Experimental Procedures 
Cortical Cell Cultures 
El4 Cultures 
The cortex from E13-14 animals was dissected in ice-cold HBSS (6.5 
gllglucose) and transferred to culture media(glutamine-free L15 [ICN] 
with 30 mM glucose, 25.6 mM NaHC03, 1% N2 supplement [Gibco] 
with penicillin-streptomycin). The tissue was gently triturated with a 
fire-polished glass Pasteur pipet to yield small clusters of cells (5-20 
cells per cluster). Cells were plated onto polylysine-laminin-coated 
plastic (24 well, Costar) or glass (4 well, Nunc) tissue culture plates 
at a density of approximately 100 clusters per well. 
El7-18, PO Cultures 
The cortex was dissected in HBSS and transferred to an enzyme solu- 
tion(Papain, lOU/ml)for2 x 20min. Followingtwowasheswithtrypsin 
inhibitor, the tissue was transferred to culture media and triturated to 
yield a single cell suspension. Cells were plated in polylysine-laminin- 
coated plates at a density of 2 x 10” cells per 60 mm plate or lo5 
cells per well in 24 well plates. 
Growth Factors and Antibodies 
All growth factors were diluted in PBS and were obtained from the 
following sources: bFGF and NT-4/5, Amgen; BDNF and NT-3, Amgen- 
Regeneron Partnership; NGF, David Ginty, HMS; CNTF, Regeneron; 
platelet derived growth factor, Chuck Stiles, Dana-Farber Cancer Insti- 
tute; epidermal growth factor, Collaborative Research; LIF, Seth Field, 
HMS. Anti-NT-3 (103) and anti-BDNF (679-l) (turkey antibodies) were 
obtained from Dr. J. Carnahan (Amgen). 
Treatment of Cultures and Data Analysis 
Unless otherwise indicated, growth factors were added at a final con- 
centration of 40 nglml. In long-term experiments, factors were supple- 
mented every third day. Anti-NT-3 and anti-BDNF were added at 10 
Ml/ml media and were not supplemented. In each experiment, cells 
were treated in duplicate, and each experiment was repeated 2-3 
times. For cell counts, data are indicated as mean f SEM. The statisti- 
cal significance of variations was evaluated using Student’s t test (pair- 
wise comparisons), and statistically significant differences compared 
with controls (p < .05) are indicated with a dot in the figures. 
BrdU Labeling and Visualization 
BrdU (Boehringer Mannheim) was diluted in sterile dHzO and added 
to cultures at a final concentration of 10 PM. For BrdU immunocylo- 
chemistry, cells were fixed with 4% paraformaldehydel49 sucrose in 
PBS for 15 min and subsequently processed as follows: rinse with 
PBS, 3 x 5 min, postfix in 70% EtOH, 30 min; rinse with PBS, permea- 
bilize with 0.4% Triton-100 in PBS, 30 min; rinse with PBS, 2N HCI, 
10 min, O.lM NaB207. 10 min; rinse with PBS, block with 3% BSA, 
3% goat serum, 0.3% Triton in PBS, 1 hr; incubate in mouse anti-BrdU 
(Becton Dickinson) 1:50 in blocking solution O/N at 4%. For peroxi- 
dase-based immunocytochemistry, a Vectastain kit (Vector Labs, CA) 
was used. For immunofluorescence, cells were washed extensively 
after primaryantibodyincubation, incubated in fluorescein-conjugated 
goat anti-mouse secondary for 1 hr, washed extensively, and viewed 
under fluorescein epifluorescence optics. All immunofluorescence 
was performed on cells growing on 4 well Nunc glass culture chambers. 
lmmunocytochemlstry 
For all antigens other than BrdU, cells were fixed in 4% paraformal- 
dehyde/4% sucrose in PBS for 15 min, blocked in 3% BSA, 3% goat 
serum, 0.3% Triton in PBS for 1 hr, and immunostained according to 
standard procedures. For immunofluorescence, mouse primary anti- 
bodies were detected with fluorescein-conjugated goat anti-mouse 
secondary antibodies. and rabbit primary antibodies were detected 
using Texas Red-conjugated goat anti-rabbit second&y antibodies. 
Antibodies were used at the following dilution: anti-nestin (from Dr. Ron 
McKay, NIH) at 1:50; anti-MAP2 (from Dr. Richard Vallee, Worcester 
Foundation for Experimental Biology) at 1:5000; anti-TuJl (from Dr. 
Brenda Williams, Boston Biomedical Research Institute) at 1:5000; 
anti-GFAP (Sigma) at 1:500; anti-galctocerebroside (Sigma) at 1500; 
anti-Trk 203 (from Dr. David Kaplan, NCI) at 1:200; anti-phospho CREB 
(from Dr. David Ginty, HMS) at 1:lOOO. 
Protein Blots 
Cells growing in 60 mm plates were stimulated with growth factors for 
5 min before being lysed in 100 pl of boiling SDS lysis buffer (160 mM 
Tris-HCI [pH 6.61. 4% SDS, 30% glycerol, 5% B-mercaptoethanol, 10 
mM DTT, 0.02% bromphenol blue). Lysates were loaded on an 6.5% 
polyacrylamide gel, separated by gel electrophoresis, transferred to 
nitrocellulose and immunoblotted using phosphotyrosine antibodies 
(1:10004GlC IUBI] and 1 : lOOO Py20]ICN]), and visualized using elec- 
trochemiluminescence. 
RNA Blots 
Total cellular RNA from cells growing in 60 mm plates was isolated 
using the guanidinium thiocyanate method (Chomczynski and Sacchi, 
1967). RNA was loaded at 15 pg per lane of a 1.4% agaroselformalde- 
hyde gel, transferred to nylon membranes, and hybridized with a 
“P-labeled probe to the coding region of the c-fos cDNA. 
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